Summary[1]Edit
Medic Bleep replaced pagers in a NHS Hospital and is used by 4,200 of their staff. It is saving each nurse & each junior doctor an estimated 21 minutes & 48 minutes per shift. This coincides with the Department of Health calling for a ban on pagers. If implemented across the NHS it could free up the time to care for est 11,000 nurses.
- Estimated average efficiency saving of £2.5 million per NHS Trust per year
- Peer reviewed paper; saving 21 & 48 mins for each nurse & doctor/shift
- Over £2 million investment to date by Directors
- NHS to remove pagers by 2021; Medic Bleep work cited by Dep of Health
Operations[1]Edit
Medic Bleep is a secure and real-time communication solution. It enables doctors, nurses and the wider team to communicate and collaborate more effectively, accelerating productivity, reducing costs, and improving patient outcomes.
Replacing traditional pagers, switchboard, landline and fax methodology which exist across the NHS and healthcare system globally. These communication modalities are one way and one to one. Medic Bleep reimagines this for the healthcare system.
Our research suggests that poor inter team communication is the primary cause for 21% of patient harm; meaning a possible 400,000 episodes of potential harm a year, in the NHS alone.
There are over 1.1 million staff in the NHS alone and this is a challenge which clearly needs resolving; reflected by the 16,000 downloads by UK doctors and nurses to date.
We have been highly commended as the Healthcare Technology Solution of the Year by Industry journalists.
Our peer review paper and work has been cited by Department of Health as an example for Hospitals across the NHS when introducing the ban on pager use in the NHS for 2021 and mentioned in the House of Commons.
For regulatory reasons, we only allow communication to occur via the app if the Trust/CCG has signed up to its use across the organisation
We aim to solve this challenge for over 30% of the NHS in the next 3 years and work with healthcare providers globally.
Team[1]Edit
Dr Sandeep Bansal, Founder and CEO is a doctor with a postgraduate degree in Paediatrics.
He is an Innovation Mentor at the Royal College of GPs alongside advisor for Harvard Medical School for Postgraduate Teaching for Surgical Leadership.
He saw the challenges in communication and patients having to repeat information to the doctors and nurses. Although the NHS is one system, he saw that it clearly was not one system for its patients. With empirical evidence of NHS staff using WhatsApp (which is non compliant with NHS data regulations), he was passionate about delivering the right information to the right healthcare professional at the right time and to connect the world of health and social care.
Sir Professor Bruce Keogh is ex NHS England Medical Director and presently Chair of Birmingham Women's and Children's NHS Foundation Trust. He is an advisor to the board.
Prof Shafi Ahmed (Part-time)is the worlds most watched surgeon and currently advisor to UAE government on the digital transformation of health and innovation.
Kevin McDonnell gained 70% market share in the NHS in England and Wales with a previous product which he went on to successfully exit.
Our team are highly qualified and have robust experience working to impact the NHS. They share expertise in understanding sales and successful implementations, as well as management of patient safety, governance and regulation.
RisksEdit
As with any investment, investing in Medic Bleep carries a level of risk. Overall, based on the key risks highlighted below, the degree of risk associated with an investment in Medic Bleep is higher than in a company that's trading on a public market.
Early-stage investmentEdit
Medic Bleep is at one of the earliest stages of the business lifecycle, and the failure rate of companies at that stage is usually much higher than those at a later stage.
Illiquid investmentEdit
The number of transactions in shares of private companies is usually significantly lower than in public companies, typically resulting in it taking longer to sell shares in private companies at a price that is at least equal to the price that the shares were bought at. Accordingly, the Medic Bleep investment opportunity is considered to be higher risk than more liquid companies.
References and notesEdit